Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., et al. (2012) · International Journal of Transgenderism · doi:10.1080/15532739.2011.700873 · Cited by 3,143
(2006) · PsycEXTRA Dataset · doi:10.1037/e545592006-001 · Cited by 2,958
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,698
Self-citationAuvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,349
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Self-citationAntiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
Antiretroviral therapy for the prevention of HIV-1 transmission.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600693 · Cited by 1,700
White Hughto, J. M., Reisner, S. L., & Pachankis, J. E. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.11.010 · Cited by 1,680
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L. J., Chico, R. M., Smolak, A., Newman, L., Gottlieb, S., et al. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.228486 · Cited by 1,665
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Temporal Dynamics of the Human Vaginal Microbiota
Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J., Schütte, U. M. E., Zhong, X., Koenig, S. S. K., Fu, L., Ma, Z. (., Zhou, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003605 · Cited by 1,558
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.
Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70315-8 · Cited by 1,461
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.5148 · Cited by 1,431
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10897 · Cited by 1,409
Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., Huh, W. K., Kim, J. J., Moscicki, A.-B., Nayar, R., et al. (2020) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000525 · Cited by 1,406
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M.-C., Baldo, V., Brassard, P., Brotherton, J. M. L., Callander, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30298-3 · Cited by 1,384
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Transgender people: health at the margins of society
Winter, S., Diamond, M., Green, J., Karasic, D., Reed, T., Whittle, S., & Wylie, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00683-8 · Cited by 1,163
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,144
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Meites, E., Szilagyi, P. G., Chesson, H. W., Unger, E. R., Romero, J. R., & Markowitz, L. E. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6832a3 · Cited by 1,025
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30418-0 · Cited by 1,023
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.lgt200570 · Cited by 1,007
Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement
Clsi (2010) · Cited by 987
Kamb, M. L., Fishbein, M., Douglas, Jr., Rhodes, F., Rogers, J., Bolan, G., Zenilman, J., Hoxworth, T., Malotte, C. K., Iatesta, M., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1161 · Cited by 973
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
COREY, L., ADAMS, H. G., BROWN, Z. A., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-958 · Cited by 931
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
Scholes, D., Stergachis, A., Heidrich, F. E., Andrilla, H., Holmes, K. K., & Stamm, W. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342103 · Cited by 847
Condom effectiveness in reducing heterosexual HIV transmission.
Weller, S. C., & Davis-Beaty, K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003255 · Cited by 846
Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery
COTCH, M. F., PASTOREK, J. G., NUGENT, R. P., HILLIER, S. L., GIBBS, R. S., MARTIN, D. H., ESCHENBACH, D. A., EDELMAN, R., CAREY, C. J., REGAN, J. A., et al. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199707000-00008 · Cited by 836
Evaluation and Management of Penicillin Allergy: A Review
Shenoy, E. S., Macy, E., Rowe, T., & Blumenthal, K. G. (2019) · JAMA · doi:10.1001/jama.2018.19283 · Cited by 830
Macy, E., & Contreras, R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.021 · Cited by 829
Papp, J. R., Schachter, J., Gaydos, C. A., & Pol, B. J. V. D. (2014) · PubMed · Cited by 823
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
The Acquisition of Herpes Simplex Virus during Pregnancy
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 782
Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.
Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506110 · Cited by 772
U.S. Selected Practice Recommendations for Contraceptive Use, 2016
Curtis, K. M., Jatlaoui, T. C., Tepper, N. K., Zapata, L. B., Horton, L. G., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6504a1 · Cited by 766
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761
Estimating per-act HIV transmission risk: a systematic review
Patel, P., Borkowf, C. B., Brooks, J. T., Lasry, A., Lansky, A., & Mermin, J. (2014) · AIDS · doi:10.1097/qad.0000000000000298 · Cited by 748
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Effectiveness of condoms in preventing sexually transmitted infections.
Holmes, K., Levine, R., & Weaver, M. R. (2004) · Bulletin of the World Health Organization · doi:10.1590/s0042-96862004000600012 · Cited by 728
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035144 · Cited by 720
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703
Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA · doi:10.1001/jama.2018.8431 · Cited by 698
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696
Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women
Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., & Koutsky, L. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053284 · Cited by 694
Carcinogenicity of human papillomaviruses
Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., & Ghissassi, F. E. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70086-3 · Cited by 688
Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., & Corey, L. (2003) · JAMA · doi:10.1001/jama.289.2.203 · Cited by 679
Risk factors for HIV infection among men who have sex with men.
Koblin, B. A., Husnik, M. J., Colfax, G., Huang, Y., Madison, M., Mayer, K., Barresi, P. J., Coates, T. J., Chesney, M. A., & Buchbinder, S. (2006) · AIDS · doi:10.1097/01.aids.0000216374.61442.55 · Cited by 678
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
Carey, J. C., Klebanoff, M. A., Hauth, J. C., Hillier, S. L., Thom, E. A., Ernest, J. M., Heine, R. P., Nugent, R. P., Fischer, M. L., Leveno, K. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420802 · Cited by 673
Guidelines for the use of antiretroviral agents in pediatric HIV infection: (477722008-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e477722008-001 · Cited by 670
Effectiveness of condoms in preventing sexually transmitted infections.
(2004) · Europe PMC (PubMed Central) · Cited by 655
Unemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., & Sednaoui, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05760-11 · Cited by 653
Drolet, M., Bénard, É., Boily, M.-C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J. M. L., Cummings, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71073-4 · Cited by 642
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
Hauth, J. C., Goldenberg, R. L., Andrews, W. W., DuBard, M. B., & Copper, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332603 · Cited by 609
Lukehart, S. A., Hook, E. W., Baker-Zander, S. A., Collier, A. C., Critchlow, C. W., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-855 · Cited by 603
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Becasen, J. S., Denard, C. L., Mullins, M. M., Higa, D. H., & Sipe, T. A. (2019) · American Journal of Public Health · doi:10.2105/ajph.2018.304727 · Cited by 590
The natural history of human papillomavirus infection
de Sanjosé, S., Brotons, M., & Pavón, M. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.015 · Cited by 589
Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color.
Sevelius, J. M. (2013) · Sex Roles · doi:10.1007/s11199-012-0216-5 · Cited by 572
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 558
Rolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550
Self-citationKent, C. K., Chaw, J. K., Wong, W., Liska, S., Gibson, S., Hubbard, G., & Klausner, J. D. (2005) · Clinical Infectious Diseases · doi:10.1086/430704 · Cited by 541
Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
Taylor-Robinson, D., & Jensen, J. S. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-11 · Cited by 537
Garland, S. M., Steben, M., Sings, H. L., James, M., Lu, S., Railkar, R., Barr, E., Haupt, R. M., & Joura, E. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597071 · Cited by 532
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
Kreisel, K. M., Spicknall, I. H., Gargano, J. W., Lewis, F. M. T., Lewis, R. M., Markowitz, L. E., Roberts, H., Johnson, A. S., Song, R., St. Cyr, S. B., et al. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001355 · Cited by 530
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904849 · Cited by 524
Bavinton, B. R., Pinto, A. N., Phanuphak, N., Grinsztejn, B., Prestage, G. P., Zablotska-Manos, I. B., Jin, F., Fairley, C. K., Moore, R., Roth, N., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30132-2 · Cited by 524
Risks of chronicity following acute hepatitis B virus infection: a review.
Hyams, K. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.992 · Cited by 521
Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit192 · Cited by 521
Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America
Silverberg, M. J., Lau, B., Justice, A. C., Engels, E., Gill, M. J., Goedert, J. J., Kirk, G. D., D'Souza, G., Bosch, R. J., Brooks, J. T., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1012 · Cited by 520
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.
Tobian, A. A. R., Serwadda, D., Quinn, T. C., Kigozi, G., Gravitt, P. E., Laeyendecker, O., Charvat, B., Ssempijja, V., Riedesel, M., Oliver, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802556 · Cited by 512
Minkoff, H., Grunebaum, A. N., Schwarz, R. H., Feldman, J., Cummings, M., Crombleholme, W., Clark, L., Pringle, G., & McCormack, W. M. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90392-2 · Cited by 511
Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., Govender, S., De Kock, A., Cassim, N., Palanee, T., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61842-5 · Cited by 502
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 496
High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis
Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S., & Barnabas, R. V. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000972 · Cited by 493
Marra, C. M., Maxwell, C. L., Smith, S. L., Lukehart, S. A., Rompalo, A. M., Eaton, M., Stoner, B. P., Augenbraun, M., Barker, D. E., Corbett, J. J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381227 · Cited by 491
Sutton, M., Sternberg, M., Koumans, E. H., McQuillan, G., Berman, S., & Markowitz, L. (2007) · Clinical Infectious Diseases · doi:10.1086/522532 · Cited by 490
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019) · Hepatology · doi:10.1002/hep.30297 · Cited by 486
The impact of a reported penicillin allergy on surgical site infection risk.
Blumenthal, K. G., Ryan, E. E., Li, Y., Lee, H., Kuhlen, J. L., & Shenoy, E. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix794 · Cited by 481
Adherent Biofilms in Bacterial Vaginosis
Swidsinski, A., Mendling, W., Loening-Baucke, V., Ladhoff, A., Swidsinski, S., Hale, L. P., & Lochs, H. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000183594.45524.d2 · Cited by 481
Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.
Nel, A., van Niekerk, N., Kapiga, S., Bekker, L.-G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602046 · Cited by 479
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00672 · Cited by 475
Brown, Z. A., Benedetti, J., Ashley, R., Burchett, S., Selke, S., Berry, S., Vontver, L. A., & Corey, L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105023241804 · Cited by 473
Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30089-9 · Cited by 472
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470
Golden, M. R., Whittington, W. L. H., Handsfield, H. H., Hughes, J. P., Stamm, W. E., Hogben, M., Clark, A., Malinski, C., Helmers, J. R. L., Thomas, K. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041681 · Cited by 470
Casey, L. S., Reisner, S. L., Findling, M. G., Blendon, R. J., Benson, J. M., Sayde, J. M., & Miller, C. (2019) · Health Services Research · doi:10.1111/1475-6773.13229 · Cited by 467
Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis
Srinivasan, S., Liu, C., Mitchell, C. M., Fiedler, T. L., Thomas, K. K., Agnew, K. J., Marrazzo, J. M., & Fredricks, D. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010197 · Cited by 465
Klebanoff, M. A., Carey, J. C., Hauth, J. C., Hillier, S. L., Nugent, R. P., Thom, E. A., Ernest, J. M., Heine, R. P., Wapner, R. J., Trout, W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003329 · Cited by 461
Mycoplasma genitalium Infection and Female Reproductive Tract Disease: A Meta-analysis
Lis, R., Rowhani-Rahbar, A., & Manhart, L. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ312 · Cited by 460
Brüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598327 · Cited by 457
Celum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., Cowan, F., Casapia, M., Ortiz, A., Fuchs, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60920-4 · Cited by 449
Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30725-9 · Cited by 449
Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Cornelisse, V. J., Doyle, J. S., & Stoové, M. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy182 · Cited by 447
Surveillance of vaccination coverage among adult populations—United States, 2015.
Williams, W. W., Lu, P.-J., O’Halloran, A., Kim, D. K., Grohskopf, L. A., Pilishvili, T., Skoff, T. H., Nelson, N. P., Harpaz, R., Markowitz, L. E., et al. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6611a1 · Cited by 442
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001014 · Cited by 439
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
Van Damme, L., Govinden, R., Mirembe, F. M., Guédou, F., Solomon, S., Becker, M. L., Pradeep, B. S., Krishnan, A. K., Alary, M., Pande, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707957 · Cited by 438
Red Book 2015: Report of the Committee on Infectious Diseases
Kimberlin, D. W., Barnett, E. D., Lynfield, R., & Sawyer, M. H. (2015) · doi:10.1542/9781610025782 · Cited by 436
Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999-2010
Bradley, H., Markowitz, L. E., Gibson, T., & McQuillan, G. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jit458 · Cited by 432
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
Benedetti, J., Corey, L., & Ashley, R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00004 · Cited by 428
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study
Plummer, M., Herrero, R., Franceschi, S., Meijer, C. J. L. M., Snijders, P., Bosch, F. X., de Sanjosé, S., & Muñoz, N. (2003) · Cancer Causes & Control · doi:10.1023/b:caco.0000003811.98261.3e · Cited by 423
Objectivized diagnosis of acute pelvic inflammatory disease
Jacobson, L., & Weström, L. (1969) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(69)90132-x · Cited by 422
Liu, G., Sharma, M., Tan, N., & Barnabas, R. V. (2018) · AIDS · doi:10.1097/qad.0000000000001765 · Cited by 421
Brotman, R. M., Klebanoff, M. A., Nansel, T. R., Yu, K. F., Andrews, W. W., Zhang, J., & Schwebke, J. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/657320 · Cited by 418
Ness, R. B., Soper, D. E., Holley, R. L., Peipert, J., Randall, H., Sweet, R. L., Sondheimer, S. J., Hendrix, S. L., Amortegui, A., Trucco, G., et al. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121625 · Cited by 414
Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020
St. Cyr, S., Barbee, L., Workowski, K. A., Bachmann, L. H., Pham, C., Schlanger, K., Torrone, E., Weinstock, H., Kersh, E. N., & Thorpe, P. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6950a6 · Cited by 412
Self-citationDanta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T'Sjoen, G. G. (2017) · Endocrine Practice · doi:10.4158/1934-2403-23.12.1437 · Cited by 408
Targeted PCR for Detection of Vaginal Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., Thomas, K. K., Oakley, B. B., & Marrazzo, J. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01272-07 · Cited by 406
Natural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
Mast, E. E., Hwang, L., Seto, D. S. Y., Nolte, F. S., Nainan, O. V., Wurtzel, H., & Alter, M. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497701 · Cited by 396
Human Papillomavirus–Attributable Cancers — United States, 2012–2016
Senkomago, V., Henley, S. J., Thomas, C. C., Mix, J. M., Markowitz, L. E., & Saraiya, M. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6833a3 · Cited by 396
Roberts, C. M., Pfister, J. R., & Spear, S. J. (2003) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000092387.58746.c7 · Cited by 379
Evaluation of Vaginal Complaints
Anderson, M. R. (2004) · JAMA · doi:10.1001/jama.291.11.1368 · Cited by 378
Macrolide Resistance in Treponema pallidum in the United States and Ireland
Lukehart, S. A., Godornes, C., Molini, B. J., Sonnett, P., Hopkins, S., Mulcahy, F., Engelman, J., Mitchell, S. J., Rompalo, A. M., Marra, C. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040216 · Cited by 378
Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis
Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915254 · Cited by 377
Self-citationKuhar, D. T., Henderson, D. K., Struble, K. A., Heneine, W., Thomas, V., Cheever, L. W., Gomaa, A., Panlilio, A. L., & US Public Health Service Working Group (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/672271 · Cited by 377
Lalor, K., & McElvaney, R. (2010) · Trauma, Violence, & Abuse · doi:10.1177/1524838010378299 · Cited by 376
Safrin, S., Crumpacker, C., Chatis, P., Davis, R., Hafner, R., Rush, J., Kessler, H. A., Landry, B., & Mills, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108223250805 · Cited by 375
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Kiweewa, F. M., Nair, G., Mhlanga, F., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489577.60775.40 · Cited by 372
Jaffee, K. D., Shires, D. A., & Stroumsa, D. (2016) · Medical Care · doi:10.1097/mlr.0000000000000583 · Cited by 368
Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion.
Bernstein, K. T., Marcus, J. L., Nieri, G., Philip, S. S., & Klausner, J. D. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c3ef29 · Cited by 360
Ugwumadu, A., Manyonda, I., Reid, F., & Hay, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12823-1 · Cited by 360
Blumenthal, K. G., Lu, N., Zhang, Y., Li, Y., Walensky, R. P., & Choi, H. K. (2018) · BMJ · doi:10.1136/bmj.k2400 · Cited by 357
Roberts, L. J., Huffam, S. E., Walton, S. F., & Currie, B. J. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.08.033 · Cited by 356
Lifetime risk of a diagnosis of HIV infection in the United States
Hess, K. L., Hu, X., Lansky, A., Mermin, J., & Hall, H. I. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.02.003 · Cited by 356
Bartlett, J. A. (2004) · Infectious Diseases in Clinical Practice · Cited by 352
Eyre, D. W., Sanderson, N. D., Lord, E., Regisford-Reimmer, N., Chau, K., Barker, L., Morgan, M., Newnham, R., Golparian, D., Unemo, M., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.27.1800323 · Cited by 348
Bernstein, D. I., Bellamy, A. R., Hook, E. W., Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis891 · Cited by 348
Morales, W. J., Schorr, S., & Albritton, J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70033-8 · Cited by 347
Sevelius, J. M., Patouhas, E., Keatley, J. G., & Johnson, M. O. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9565-8 · Cited by 345
Clinical experience with penicillin skin testing in a large inner-city STD clinic.
Gadde, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510200062033 · Cited by 344
Interventions for emergency contraception
Shen, J., Che, Y., Showell, E., Chen, K., & Cheng, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001324.pub5 · Cited by 342
Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk
Chaturvedi, A. K., Engels, E. A., Gilbert, E. S., Chen, B. E., Storm, H., Lynch, C. F., Hall, P., Langmark, F., Pukkala, E., Kaijser, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm201 · Cited by 341
Oakeshott, P., Kerry, S., Aghaizu, A., Atherton, H., Hay, S., Taylor-Robinson, D., Simms, I., & Hay, P. (2010) · BMJ · doi:10.1136/bmj.c1642 · Cited by 340
Camara, J., Serra, J., Ayats, J., Bastida, T., Carnicer-Pont, D., Andreu, A., & Ardanuy, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks162 · Cited by 339
A Cluster Analysis of Bacterial Vaginosis–associated Microflora and Pelvic Inflammatory Disease
Ness, R. B., Kip, K. E., Hillier, S. L., Soper, D. E., Stamm, C. A., Sweet, R. L., Rice, P., & Richter, H. E. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi243 · Cited by 338
Sogn, D. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170105020 · Cited by 337
McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61086-0 · Cited by 335
Intrauterine device and upper-genital-tract infection
Grimes, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02699-4 · Cited by 333
Wald, A., Huang, M., Carrell, D., Selke, S., & Corey, L. (2003) · The Journal of Infectious Diseases · doi:10.1086/379043 · Cited by 330
Chan, P. A., Robinette, A., Montgomery, M., Almonte, A., Cu-Uvin, S., Lonks, J. R., Chapin, K. C., Kojic, E. M., & Hardy, E. J. (2016) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2016/5758387 · Cited by 330
Self-citationDeshmukh, A. A., Suk, R., Shiels, M. S., Sonawane, K., Nyitray, A. G., Liu, Y., Gaisa, M. M., Palefsky, J. M., & Sigel, K. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz219 · Cited by 327
Repeat Infection With Chlamydia and Gonorrhea Among Females: A Systematic Review of the Literature
Hosenfeld, C. B., Workowski, K. A., Berman, S., Zaidi, A., Dyson, J., Mosure, D., Bolan, G., & Bauer, H. M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a2a933 · Cited by 326
Self-citationTesting for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
Getchell, J. P., Wroblewski, K., DeMaria, A., et al. (2013) · PubMed Central · Cited by 325
Kreimer, A. R., Rodriguez, A. C., Hildesheim, A., Herrero, R., Porras, C., Schiffman, M., González, P., Solomon, D., Jiménez, S., Schiller, J. T., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr319 · Cited by 324
Bruce, M. G., Bruden, D., Hurlburt, D., Zanis, C., Thompson, G., Rea, L., Toomey, M., Townshend-Bulson, L., Rudolph, K., Bulkow, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv748 · Cited by 322
Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women
Wald, A. (2001) · JAMA · doi:10.1001/jama.285.24.3100 · Cited by 321
Safety of metronidazole in pregnancy: A meta-analysis
Burtin, P., Taddio, A., Ariburnu, O., Einarson, T. R., & Koren, G. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90567-7 · Cited by 320
Risk of anaphylaxis after vaccination of children and adolescents.
Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team (2003) · PEDIATRICS · doi:10.1542/peds.112.4.815 · Cited by 320
Prospective study of perinatal transmission of Chlamydia trachomatis.
Schachter, J. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370240044034 · Cited by 320
Permethrin and ivermectin for scabies.
Currie, B. J., & McCarthy, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmct0910329 · Cited by 319
Brusselaers, N., Shrestha, S., van de Wijgert, J., & Verstraelen, H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.011 · Cited by 317
Interventions for treating scabies
Strong, M., & Johnstone, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000320.pub2 · Cited by 315
van de Laar, T., Pybus, O., Bruisten, S., Brown, D., Nelson, M., Bhagani, S., Vogel, M., Baumgarten, A., Chaix, M.-L., Fisher, M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.006 · Cited by 315
Self-reported antibiotic allergy incidence and prevalence: age and sex effects.
Macy, E., & Poon K-Y, T. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.034 · Cited by 313
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.6390 · Cited by 312
Johnson, L. F., & Lewis, D. A. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181812d15 · Cited by 311
Vandelli, C., Renzo, F., Romano, L., Tisminetzky, S., De Palma, M., Stroffolini, T., Ventura, E., & Zanetti, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04150.x · Cited by 310
Condyloma in pregnancy is strongly predictive of Juvenile-Onset recurrent respiratory papillomatosis
Silverberg, M. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)03081-8 · Cited by 307
Screening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1981 · Cited by 304
Ahmed, K., Baeten, J. M., Beksinska, M., Bekker, L.-G., Bukusi, E. A., Donnell, D., Gichangi, P. B., Heller, K. B., Hofmeyr, G. J., Justman, J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31288-7 · Cited by 299
Practice Bulletin No. 131: Screening for Cervical Cancer
(2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318277c92a · Cited by 298
Tronstein, E. (2011) · JAMA · doi:10.1001/jama.2011.420 · Cited by 298
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
Riedner, G., Rusizoka, M., Todd, J., Maboko, L., Hoelscher, M., Mmbando, D., Samky, E., Lyamuya, E., Mabey, D., Grosskurth, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044284 · Cited by 296
SCHACHTER, J., MONCADA, J., LISKA, S., SHAYEVICH, C., & KLAUSNER, J. D. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31817bdd7e · Cited by 293
Cahill, S., Singal, R., Grasso, C., King, D., Mayer, K., Baker, K., & Makadon, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107104 · Cited by 288
Dooley, S. W., Dubose, O., Fletcher, J. F., Gunter, D., Hogben, M., Reid, L. C., Stuckey, A. E., Viall, A. H., Whitfield, C. D., & Wright-Schnapp, T. (2008) · PubMed · Cited by 287
Auvert, B., Sobngwi-Tambekou, J., Cutler, E., Nieuwoudt, M., Lissouba, P., Puren, A., & Taljaard, D. (2009) · Journal of Infectious Diseases · doi:10.1086/595566 · Cited by 285
van de Laar, T. J. W., van der Bij, A. K., Prins, M., Bruisten, S. M., Brinkman, K., Ruys, T. A., van der Meer, J. T. M., Vries, H. J. C. D., Mulder, J., Agtmael, M. V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518796 · Cited by 284
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
